Profound Medical Corp. announced this week that treatments utilizing its TULSA-PRO® technology of Benign Prostatic Hyperplasia (“BPH”) are now being successfully conducted in Germany.
Two OBIO companies are one step from the finals of this year's Interface Health Challenge X competition, making it into the Top 25 companies:
On Monday, at Synaptive Medical's Toronto facility, Hon. Patty Hajdu, Minister of Employment, Workforce Development and Labour announced increased funding for the federal government's Student Work-Integrated Learning Program
As part of a federal cabinet shuffle announced on Monday, Canada has a new Minister of Health. In total, six cabinet portfolios changed: Health, Public Services and Procurement, Indigenous Services, Crown-Indigenous Relations and Northern Affairs, Minister of Veterans Affairs & Minister of Sport and Persons with Disabilities
OBIO’s H2BB™ program connects business talent from graduate level programs across Ontario with health science companies who need interns to help them address key commercialization goals.
The Consulate General of Canada in Boston and MassMEDIC invite emerging Canadian medtech companies to apply to participate in Canadian Mission to MassMEDIC’s MedTech Showcase, on October 26-27, 2017.
Sernova Corp, a leading clinical stage regenerative medicine company, announced that FronTier Merchant Capital Group will provide North American investor relations (IR) and strategic marketing for Sernova with a goal of increasing market awareness through financial market communications.
Six OBIO companies have advanced to the semi-final round of this year's Interface Health Challenge X competition, making it into the Top 50 companies
A new study conducted bythe Canadian Concussion Centre and Dr. Charles Tator has shown that Iris Technologies' Non-LCD E-Paper Technology can decrease the risk of exacerbating symptoms in sufferers of post-concussion syndrome (PCS).
US FDA unveiled its Digital Health Innovation Action Plan last week, including a Software Pre-Certification Pilot Program to facilitate faster market access for digital health products.